Seizures during intracarotid methohexital and amobarbital testing.

Seizures during intracarotid methohexital and amobarbital testing. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Seizures during intracarotid methohexital and amobarbital testing. Abstract Text:

Tobias Loddenkemper,Gabriel ,Stephan U Schuele,Elaine Wyllie,Harold H Morris,

BACKGROUND: Methohexital and amobarbital have been used as agents for Wada testing in the presurgical evaluation of patients with epilepsy. Previous experience with methohexital as an anesthetic indicates that methohexital may decrease seizure threshold and may trigger seizures. METHODS: A retrospective chart review of 760 intracarotid amobarbital and methohexital tests was performed to determine the frequency of seizures associated with preoperative intracarotid barbiturate testing for language and memory lateralization. RESULTS: Sixteen patients (2.1%) who had seizures were found. In 3 patients, seizures occurred prior to barbiturate injection, and in 13, following barbiturate injection. After injection of amobarbital, 4 of 538 patients (0.7%) had a seizure. Nine of 222 patients had a seizure after methohexital injection (4.1%) (P=0.001). CONCLUSION: Patients with a previous history of epilepsy may be at higher risk for seizures after methohexital injection as compared with amobarbital injection.

Seizures during intracarotid methohexital and amobarbital testing. Publishing Authors By Initials

T Loddenkemper,G ,SU Schuele,E Wyllie,HH Morris,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Seizures during intracarotid methohexital and amobarbital testing. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Epilepsy & behavior : E&B

VOLUME: 10

Page Numbers: 49-54

Journal Abbreviation:

ISSN: 1525-5050

DAY: 16

MONTH: 10

YEAR: 2006

Seizures during intracarotid methohexital and amobarbital testing. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100892858

Seizures during intracarotid methohexital and amobarbital testing. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Seizures during intracarotid methohexital and amobarbital testing. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Seizures during intracarotid methohexital and amobarbital testing.

AFFILIATION: Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Epilepsy Behav

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Seizures during intracarotid methohexital and amobarbital testing Related Publications

• BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
• Cdc42 and ARP2/3-independent regulation of filopodia by an integral membrane lipid-phosphatase-related protein.
• Cell- and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation.
• Characterization of monocarboxylate transport in human kidney HK-2 cells.
• Clinical dementia rating workshop: the Asian experience.
• Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension.
• Development of antibodies and chimeric molecules for cancer immunotherapy.
• Driving and dementia in older adults: Implementation and evaluation of a continuing education project.
• Dual Stretch Responses of mHCN2 Pacemaker Channels: Accelerated Activation, Accelerated Deactivation.
• Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.
• Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults.
• Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
• Identifying chemical changes in subchondral bone taken from murine knee joints using Raman spectroscopy.
• Improving standards in orthognathic care: the bigger picture (a national and international perspective).
• Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells.
• Nocturnal hypertension in mice consuming a high fructose diet.
• Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.
• Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture.
• Regulation of Product Synthesis in Cell Cultures of Catharanthus roseus. II. Comparison of Production Media1.
• Regulation of Product Synthesis in Cell Cultures of Catharanthus roseus. III. Alkaloid Metabolism in Cultured Leaf Tissue and Primary Callus1.
• Relationship between renal and cardiovascular changes in a murine model of glucose intolerance.
• Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2).
• Retroviral Vectors Encoding a Reverse Transcription-activated Transgene Efficiently Limit Expression of the Gene to Target Cells.
• Role of the transcription activator Ste12p as a repressor of PRY3 expression.
• Rotary spray congealing of a suspension: effect of disk speed and dispersed particle properties.
• Seizures during intracarotid methohexital and amobarbital testing.
• Stress cardiovascular/autonomic interactions in mice.
• The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage.
• The role of infertility nurses in ovulation induction programmes.
• Urinary oxytocin as a non-invasive biomarker for neurohypophyseal hormone secretion.